Sampath Anand - SEC Form 4 Insider Trading Screener
CIK: 1406493 - Address: C/o Masimo Corporation, 52 Discovery, Irvine, CA 92618
5 results - 
- 
- 
- 
- 
- 
- - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2020-04-13 | MASI | Sampath Anand | EVP, Ops, Clinical Research | S - Sale+OE | $180.00 | -19,796 | 13,782 | -59% | -$3,563,280 | |||||
| D | 2019-11-20 | MASI | Sampath Anand | EVP, Ops, Clinical Research | S - Sale+OE | $155.00 | -15,000 | 12,518 | -55% | -$2,325,002 | |||||
| D | 2019-06-14 | MASI | Sampath Anand | EVP, Ops, Clinical Research | S - Sale+OE | $142.38 | -30,000 | 12,518 | -71% | -$4,271,550 | |||||
| D | 2019-01-15 | MASI | Sampath Anand | COO | S - Sale+OE | $115.00 | -30,000 | 12,518 | -71% | -$3,450,000 | |||||
| D | 2018-11-28 | MASI | Sampath Anand | COO | S - Sale+OE | $110.00 | -30,000 | 11,272 | -73% | -$3,300,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |